SPI Pharmaceuticals Inc.: The Costa Mesa company...
From Times Staff and Wire Reports
SPI Pharmaceuticals Inc.: The Costa Mesa company reported first-quarter income of $3.2 million, a 12% rise over the year-ago period. Sales were $30.6 million, down from last year’s $33.7 million. The company said its performance was led by international operations, particularly in Europe, where sales were up 17%.
Tables, D11
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
